Lacidipina Tecnigen

Lacidipine, the active ingredient in Lacidipina Tecnigen, is a calcium channel blocker presented as a tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Lacidipina Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacidipine is a calcium‑channel blocker used primarily in the management of high blood pressure.

Hypertension: lowers blood pressure by reducing peripheral vascular resistance. Essential hypertension: provides long‑acting control of systolic and diastolic pressures. Secondary hypertension: may be added when other agents are insufficient.

Lacidipine may cause a range of adverse reactions.

Common Side Effects: - Headache - Flushing - Dizziness - Peripheral edema - Nausea - Tachycardia

Serious or Rare Side Effects: - Severe hypotension - Myocardial infarction - Hepatic dysfunction - Allergic reactions including rash - Angioedema - Cardiac arrhythmias

Lacidipine should be used with careful clinical monitoring. - Dose titration: start with a low dose and adjust based on blood pressure response. - Renal impairment: monitor kidney function regularly. - Hepatic impairment: use cautiously and observe liver enzymes. - Concomitant antihypertensives: risk of additive hypotension, adjust doses accordingly. - Pregnancy: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Lacidipine can interact with several medicines.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase plasma levels. - Co‑administration with other calcium‑channel blockers can cause excessive hypotension. - Grapefruit juice can raise lacidipine concentrations.

Moderate Interactions (Monitor Closely): - Diuretics may enhance antihypertensive effect, requiring BP monitoring. - Beta‑blockers combined with lacidipine need careful blood pressure observation. - Non‑steroidal anti‑inflammatory drugs may reduce antihypertensive efficacy.